Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E ε4

Neurobiology of Aging

Volumn 29, Issue 3, 2008, Pages 329-340

  Espeseth, Thomas ^a   Westlye, Lars T ^a   Fjell, Anders M ^a   Walhovd, Kristine B ^a   Rootwelt, Helge ^b   Reinvang, Ivar ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Alzheimer's disease; Apolipoprotein E; Brain aging; Cortical morphometry; Individual differences

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; FEMALE; GENOTYPE; GROUPS BY AGE; HEMISPHERE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SIGNAL NOISE RATIO;

AGED; AGING; APOLIPOPROTEIN E4; BRAIN MAPPING; CEREBRAL CORTEX; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 38949110996     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.10.030     Document Type: Article

References (61)

1. Bartzokis G., Cummings J.L., Sultzer D., Henderson V.W., Nuechterlein K.H., and Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch. Neurol. 60 3 (2003) 393-398
2. Bondi M.W., Houston W.S., Eyler L.T., and Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64 3 (2005) 501-508
3. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., and Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343 7 (2000) 450-456
4. Braak H., and Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol. Aging 18 (1997) S85-S88
5. Bretsky P., Guralnik J.M., Launer L., Albert M., and Seeman T.E. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur studies of successful aging. Neurology 60 7 (2003) 1077-1081
6. Buckner R.L., Head D., Parker J., Fotenos A.F., Marcus D., Morris J.C., and Snyder A.C. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. NeuroImage 23 (2004) 724-738
7. Cohen R.M., Small C., Lalonde F., Friz J., and Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 57 (2001) 2223-2228
8. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
9. Dale A.M., and Sereno M.I. Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. J. Cogn. Neurosci. 5 (1993) 162-176
10. Dale A.M., Fischl B., and Sereno M.I. Cortical surface-based analysis I: segmentation and surface reconstruction. NeuroImage 9 (1999) 179-194
11. Delis D.C., Kramer J.H., Kaplan E., and Ober B.A. California Verbal Learning Test. second ed. (2000), The Psychological Corporation, San Antonio, TX
12. Den Heijer T., Oudkerk M., Launer L.J., van Duijn C.M., Hofman A., and Breteler M.M. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 59 (2002) 746-748
13. Dobbs A.R., and Rule B.G. Adult age differences in working memory. Psychol. Aging 4 4 (1989) 500-503
14. Espeseth T., Greenwood P.M., Reinvang I., Fjell A.M., Walhovd K.B., Westlye L.T., Wehling E., Lundervold A., Rootwelt H., and Parasuraman R. Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults. Cogn. Affect. Behav. Neurosci. 6 (2006) 31-43
15. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., and van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 (1997) 1349-1356
16. Fazekas F., Strasser-Fuchs S., Kollegger H., Berger T., Kristoferitsch W., Schmidt H., Schiefermeier M., Schwarz C., Kornek B., Reindl M., Huber K., Grass R., Wimmer G., Vass K., Pfeiffer K.H., Hartung H.P., and Schmidt R. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 57 (2001) 853-857
17. Fischl B., and Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 11050-11055
18. Fischl B., Sereno M.I., and Dale A.M. Cortical surface-based analysis: II. Inflation, flattening, and a surface-based coordinate system. NeuroImage 9 (1999) 195-207
19. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., and Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33 (2002) 341-355
20. Fjell A.M., Walhovd K.B., Reinvang I., Lundervold A., Salat D., Quinn B.T., Fischl B., and Dale A.M. Selective increase of cortical thickness in high-performing elderly--structural indices of optimal cognitive aging. NeuroImage 29 3 (2006) 984-994
21. Flory J.D., Manuck S.B., Ferrell R.E., Ryan C.M., and Muldoon M.F. Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am. J. Med. Genet. 96 6 (2000) 707-711
22. Gerdes L.U., Jeune B., Ranberg K.A., Nybo H., and Vaupel J.W. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a "frailty gene," not a "longevity gene". Genet. Epidemiol. 19 3 (2000) 202-210
23. Greenwood P., and Parasuraman R. Normal genetic variation, cognition, and aging. Behav. Cogn. Neurosci. Rev. 2 (2003) 278-306
24. Greenwood P.M., Lambert C., Sunderland T., and Parasuraman R. Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study. Neuropsychology 19 2 (2005) 199-211
25. Greenwood P.M., Sunderland T., Friz J., and Parasuraman R. Genetics and visual attention: Selective deficits in healthy adult carriers of the E4 allele of the apolipoprotein E gene. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 11661-11666
26. Greenwood P.M., Sunderland T., Putnam K., Levy J., and Parasuraman R. Scaling of visuospatial attention undergoes differential longitudinal change as a function of APOE genotype prior to old age: results from the NIMH BIOCARD study. Neuropsychology 19 6 (2005) 830-840
27. Huang Y., Weisgraber K.H., Mucke L., and Mahley R.W. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J. Mol. Neurosci. 23 (2004) 189-204
28. Ji Z.-S., Müllendorff K., Cheng I.H., Miranda R.D., Huang Y., and Mahley R.W. Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration. J. Biol. Chem. 281 (2006) 2683-2692
29. Kuperberg G.R., Broome M.R., McGuire P.K., David A.S., Eddy M., Ozawa F., Goff D., West W.C., Williams S.C., van der Kouwe A.J., Salat D.H., Dale A.M., and Fischl B. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch. Gen. Psychiatry 60 (2003) 878-888
30. Lemaître H., Crivello F., Dufouil C., Grassiot B., Tzourio C., Alperovitch A., and Mazoyer B. No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. NeuroImage 24 4 (2005) 1205-1213
31. Lerch J.P., Pruessner J.C., Zijdenbos A., Hampel H., Teipel S.J., and Evans A.C. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb. Cortex 15 7 (2005) 995-1001
32. Lind J., Persson J., Ingvar M., Larsson A., Cruts M., Van Broeckhoven C., Adolfsson R., Backman L., Nilsson L.G., Petersson K.M., and Nyberg L. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain 129 (2006) 1240-1248
33. Lippa C.F., Smith T.W., Saunders A.M., Hulette C., Pulaski-Salo D., and Roses A.D. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype. Neurology 48 2 (1997) 515-519
34. Luo L., and O'Leary D.D. Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 28 (2005) 127-156
35. Mahley R.W., Weisgraber K.H., and Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 5644-5651
36. Mauch D.H., Nägler K., Schumacher S., Göritz C., Müller E.-C., Otto A., and Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294 (2001) 1354-1357
37. Moffat S.D., Szekely C.A., Zonderman A.B., Kabani N.J., and Resnick S.M. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 55 (2000) 134-136
38. Pfefferbaum A., Sullivan E.V., and Carmelli D. Genetic regulation of regional microstructure of the corpus callosum in late life. Neuroreport 12 8 (2001) 1677-1681
39. Pfefferbaum A., Sullivan E.V., Swan G.E., and Carmelli D. Brain structure in men remains highly heritable in the seventh and eighth decades of life. Neurobiol. Aging 21 (2000) 63-74
40. Plassman B.L., Welsh-Bohmer K.A., Bigler E.D., Johnson S.C., Anderson C.V., Helms M.J., Saunders A.M., and Breitner J.C. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology 48 (1997) 985-989
41. Raz N. The aging brain observed in vivo: differential changes and their modifiers. In: Cabeza R., Nyberg L., and Park D.C. (Eds). The Cognitive Neuroscience of Aging (2005), Oxford University Press, New York 19-58
42. Raz N., Lindenberger U., Rodriue K.M., Kennedy K.M., Head D., Williamson A., Dahle C., Gerstorf D., and Acker J.D. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb. Cortex 15 11 (2005) 1676-1689
43. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., and Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334 12 (1996) 752-758
44. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., and Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U.S.A. 101 1 (2004) 284-289
45. Reiman E.M., Uecker A., Caselli R.J., Lewis S., Bandy D., de Leon M.J., De Santi S., Convit A., Osborne D., Weaver A., and Thibodeau S.N. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann. Neurol. 44 2 (1998) 288-291
46. Resnick S.M., Pham D.L., Kraut M.A., Zonderman A.B., and Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J. Neurosci. 23 8 (2003) 3295-3301
47. Rosas H.D., Liu A.K., Hersch S., Glessner M., Ferrante R.J., Salat D.H., van der Kouwe A., Jenkins B.G., Dale A.M., and Fischl B. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58 (2002) 695-701
48. Rosen V.M., Bergeson J.L., Putnam K., Harwell A., and Sunderland T. Working memory and apolipoprotein E: what's the connection?. Neuropsychologia 40 13 (2002) 2226-2233
49. Salat D.H., Buckner R.L., Snyder A.Z., Greve D.N., Desikan R.S.R., Busa E., Morris J.C., Dale A.M., and Fischl B. Thinning of the cerebral cortex in aging. Cereb. Cortex 14 (2004) 721-730
50. Salthouse T.A. The processing-speed theory of adult age differences in cognition. Psychol. Rev. 103 3 (1996) 403-428
51. Scoville W.B., and Milner B. Loss of recent memory after bilateral hippocampal lesions. J. Neurol. Neurosurg. Psychiatry 20 (1957) 1-21
52. Small B.J., Rosnick C.B., Fratiglioni L., and Bäckman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol. Aging 19 (2004) 592-600
53. Soininen H., Partanen K., Pitkanen A., Hallikainen M., Hanninen T., Helisalmi S., Mannermaa A., Ryynanen M., Koivisto K., and Riekkinen Sr. P. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology 45 2 (1995) 391-392
54. Spreen O., and Strauss E. A Compendium of Neuropsychological Tests: Adminstration, Norms and Commentary. second ed. (1998), Oxford University Press, New York
55. Sullivan E.V., Pfefferbaum A., Swan G.E., and Carmelli D. Heritability of hippocampal size in elderly twin men: equivalent influence from genes and environment. Hippocampus 11 6 (2001) 754-762
56. Sundstrom A., Marklund P., Nilsson L.G., Cruts M., Adolfsson R., Van Broeckhoven C., and Nyberg L. Neurology 62 11 (2004) 1963-1966
57. Teter B., Xu P.T., Gilbert J.R., Roses A.D., Galasko D., and Cole G.M. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J. Neurosci. Res. 68 (2002) 331-336
58. Toga A.W., and Thompson P.M. Genetics of brain structure and intelligence. Annu. Rev. Neurosci. 28 (2005) 1-23
59. Wechsler D. Wechsler Abbreviated Scale of Intelligence (1999), The Psychological Corporation, San Antonio, TX
60. Wilson R.S., Schneider J.A., Barnes L.L., Beckett L.A., Aggarwal N.T., Cochran E.J., Berry-Kravis E., Bach J., Fox J.H., Evans D.A., and Bennett D.A. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch. Neurol. 59 (2002) 1154-1160
61. Ye S., Huang Y., Mullendorff K., Dong L., Giedt G., Meng E.C., Cohen F.E., Kuntz I.D., Weisgraber K.H., and Mahley R.W. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 18700-18705